Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 211

Sort by

Sort Order Select

Journal Articles

Ferroptosis activates NK and CAR T cell-mediated anti-tumor immunity in Acute Myeloid Leukemia

Saurabh Kumar Gupta, Kazuharu Kamachi, Liang Zhang, Ran Zhao, Babita Kaundal, Jiangxing LV, Li Li, Venkata Lokesh Battula, Xufeng Chen, Hussein Abbas, Michael Andreeff, Jo Ishizawa

Blood (2025) 146 (Supplement 1): 1496.

https://doi.org/10.1182/blood-2025-1496

Published: 2025

Journal Articles

Transition to IRD maintenance after DRD induction significantly deepens response in transplant-ineligible NDMM: A prospective multicenter study

Qiuqing Xiang, Minqiu Lu, Bin Chu, Lei Shi, Shan Gao, Lijuan Fang, Mengzhen Wang, Shuangnian Xu, Yan Zhu, Li Wang, Junnan Li, Hua Xue, Li Li, Tingting Duan, Ting Zhang, Li Bao

Blood (2025) 146 (Supplement 1): 4059.

https://doi.org/10.1182/blood-2025-4059

Published: 2025

Journal Articles

Peripheral immune checkpoints predict prognosis and reveal PD-1/treg/IL-10 crosstalk in B cell lymphoma

Bing Pan, Sijia Li, Ruixin Zheng, Kaiyi Liu, Ruyu Ye, Yu Wang, Xiaobo Wang, Li Li

Blood (2025) 146 (Supplement 1): 7088.

https://doi.org/10.1182/blood-2025-7088

Published: 2025

Journal Articles

Immune dysregulation in newly diagnosed DLBCL: From clinical observations to molecular mechanisms

Ruixin Zheng, Yuanyuan Pan, Bing Pan, Li Li

Blood (2025) 146 (Supplement 1): 7085.

https://doi.org/10.1182/blood-2025-7085

Published: 2025

Journal Articles

Adult hemophagocytic lymphohistiocytosis: A multicenter retrospective analysis of etiology and impact on survival in China

Jingsong He, Lixia Zhu, Mengqi Xiong, Jianguo Zhang, Yinyi Zhang, Xin Guo, Linjie Li, Lihong Shou, Qunyi Guo, Shuangwei Ying, Li Li, YI LI, Zhen Cai, He Huang, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 6549.

https://doi.org/10.1182/blood-2025-6549

Published: 2025

Journal Articles

Combination of golidocitinib with chidamide for peripheral T-cell lymphoma: Possible mechanisms and therapeutic potential in inhibiting tumor proliferation and modulating the immune microenvironment

Kaiyi Liu, Bing Pan, Li Li

Blood (2025) 146 (Supplement 1): 1778.

https://doi.org/10.1182/blood-2025-1778

Published: 2025

Journal Articles

Efficacy and safety analysis of CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma after failure of bispecific antibody treatment

Fu-li Li, Jia Cong, Liang Wang

Blood (2025) 146 (Supplement 1): 1941.

https://doi.org/10.1182/blood-2025-1941

Published: 2025

Journal Articles

Efficacy and safety of azacitidine plus LDAC in newly diagnosed, frail elderly patients with Acute Myeloid Leukemia

Lixia Zhu, Li Li, Xin Guo, Gaofeng Zheng, Yi Li, Jingsong He, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 6983.

https://doi.org/10.1182/blood-2025-6983

Published: 2025

Journal Articles

Quantifying treatment-associated monocytic differentiation in AML using a single-cell based myeloid differentiation index (MDX)

Li Li, Muharrem Muftuoglu, Jiangxing LV, Mahesh Basyal, Andrea Bedoy, Ghayas Issa, Naval Daver, Michael Andreeff

Blood (2025) 146 (Supplement 1): 5273.

https://doi.org/10.1182/blood-2025-5273

Published: 2025

Journal Articles

Adverse financial events and delayed treatment initiation among patients with hematologic malignancies

Christopher Su, Li Li, Catherine Fedorenko, Andrew Cowan, Scott Ramsey, Veena Shankaran

Blood (2025) 146 (Supplement 1): 286.

https://doi.org/10.1182/blood-2025-286

Published: 2025

Journal Articles

ZFP36L2 as a promising therapeutic target in acute graft-versus-host disease: Evidence from murine models and clinical validation

Li Li, Andie Fu, Xiwen Tong, Bin Xu, Xia Mao, Ying Wang, Shiyuan Zhang, Yi Zhu, Jia Wei, Donghua Zhang

Blood (2025) 146 (Supplement 1): 5863.

https://doi.org/10.1182/blood-2025-5863

Published: 2025

Journal Articles

Gene-modified iPSC-derived MSCs convert immunosuppressive tumor microenvironments (TMEs) into distinct Pro-inflammatory tmes

Muharrem Muftuoglu, Sandeep Singh, Andrea Bedoy, Li Li, Mahesh Basyal, Nath Dipmoy, Lauren Ostermann, Ivo Veletic, Christopher Pacheco, Po Yee Mak, Edward Ayoub, Taeyun Kim, Kyle Garland, Robert Pierce, Mathew Angel, Sanjeev Luther, Christopher Rohde, Michael Andreeff

Blood (2025) 146 (Supplement 1): 263.

https://doi.org/10.1182/blood-2025-263

Published: 2025

Journal Articles

Engineered IL7/IL15 secreting iPSC-derived mesenchymal stromal cells reprogram the immunosuppressive tumor microenvironment and potentiate antitumor immunity

Sandeep Singh, Andrea Bedoy, Muharrem Muftuoglu, Li Li, Olayinka Okeleji, Nath Dipmoy, Lauren Ostermann, Ivo Veletic, Christopher Pacheco, Mahesh Basyal, Taeyun Kim, Kyle M. Garland, Mathew Angel, Sanjeev Luther, Christopher Rohde, Michael Andreeff, Vivek Anand

Blood (2025) 146 (Supplement 1): 4137.

https://doi.org/10.1182/blood-2025-4137

Published: 2025

Journal Articles

From mechanistic synergy to clinical breakthrough: Updated results from a phase II Trial of HD-MTX, selinexor, and zanubrutinib in CNS lymphoma

Li Li, Bing Pan, Kaiyi Liu, Wenjing Yang, Xin Gao, Qi Zhang, Zhijia Zhao, Yinuo Cai, Xiaobo Wang

Blood (2025) 146 (Supplement 1): 3550.

https://doi.org/10.1182/blood-2025-3550

Published: 2025

Journal Articles

Quantitative 18F-FDG-PET/CT analysis of splenic suvmax enhances diagnostic accuracy in primary splenic non-Hodgkin lymphoma

Li li, Mengqi Xiong, Lu-Lu Wang, Lixia zhu, Kui zhao, lijun wang, Jingsong He, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 3607.

https://doi.org/10.1182/blood-2025-3607

Published: 2025

Journal Articles

Correlative data from an ongoing Phase 1, multicenter study of senti-202, a first-in-class, CD33 and/or FLT3 & not endomucin (EMCN), selective off-the-shelf CAR NK cell therapy for Acute Myeloid Leukemia (AML) is consistent with its clinical activity and unique logic gated mechanism of action

Muharrem Muftuoglu, Enping Hong, Nosha Farhadfar, Stephen Strickland, Ashish Bajel, Alireza Eghtedar, Gary Schiller, Mahesh Basyal, Li Li, Lawrence Naitmazi, Rochelle Emery, Timothy Lu, Brian Garrison, Kanya Rajangam, Farhad Ravandi, Michael Andreeff

Blood (2025) 146 (Supplement 1): 5921.

https://doi.org/10.1182/blood-2025-5921

Published: 2025

Journal Articles

Reactivating mutant p53 in T cells enhances anti-tumor activity in Acute Myeloid Leukemia

Li Li, Muharrem Muftuoglu, Jiangxing LV, Edward Ayoub, Aram Bidikian, Prashant Menon, Mahesh Basyal, Andrea Bedoy, Anudishi Tyagi, Amanda Eckstrom, Venkata Lokesh Battula, Ghayas Issa, Navin Varadarajan, Bing Carter, Michael Andreeff

Blood (2025) 146 (Supplement 1): 5915.

https://doi.org/10.1182/blood-2025-5915

Published: 2025

Journal Articles

Comparisons between Haploidentical Hematopoietic Stem Cell Transplantation and Eltrombopag Adding to Standard Immunosuppression in Patients with Severe Aplastic Anemia

Andie Fu, Mengyuan Li, Yizhou Peng, Bin Xu, Li Li, Jin-song Jia, Yan Yang, Shengyun Lin, Jia Wei, Fankai Meng, Donghua Zhang, Guangsheng He

Blood (2024) 144 (Supplement 1): 3567.

https://doi.org/10.1182/blood-2024-199689

Published: 2024

Journal Articles

Associations of Long-Term Financial Hardship with Autologous Transplant and Overall Survival in Patients with Multiple Myeloma

Christopher T. Su, Rahul Banerjee, Li Li, Catherine Fedorenko, Andrew J. Cowan, Scott D. Ramsey, Veena Shankaran

Blood (2024) 144 (Supplement 1): 3661.

https://doi.org/10.1182/blood-2024-211677

Published: 2024

Journal Articles

“Guided” Unsupervised Multiplexed Cytof Analysis Enhances Detection of Minimal/Measurable Residual Disease in Acute Myeloid Leukemia

Muharrem Muftuoglu, Li Li, Mahesh Basyal, Jiangxing Lv, Yukun Tan, Ken Chen, Michael Andreeff

Blood (2024) 144 (Supplement 1): 6178.

https://doi.org/10.1182/blood-2024-212260

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Ferroptosis activates NK and CAR T cell-mediated anti-tumor immunity in Acute Myeloid Leukemia

Transition to IRD maintenance after DRD induction significantly deepens response in transplant-ineligible NDMM: A prospective multicenter study

Peripheral immune checkpoints predict prognosis and reveal PD-1/treg/IL-10 crosstalk in B cell lymphoma

Immune dysregulation in newly diagnosed DLBCL: From clinical observations to molecular mechanisms

Adult hemophagocytic lymphohistiocytosis: A multicenter retrospective analysis of etiology and impact on survival in China

Combination of golidocitinib with chidamide for peripheral T-cell lymphoma: Possible mechanisms and therapeutic potential in inhibiting tumor proliferation and modulating the immune microenvironment

Efficacy and safety analysis of CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma after failure of bispecific antibody treatment

Efficacy and safety of azacitidine plus LDAC in newly diagnosed, frail elderly patients with Acute Myeloid Leukemia

Quantifying treatment-associated monocytic differentiation in AML using a single-cell based myeloid differentiation index (MDX)

Adverse financial events and delayed treatment initiation among patients with hematologic malignancies

ZFP36L2 as a promising therapeutic target in acute graft-versus-host disease: Evidence from murine models and clinical validation

Gene-modified iPSC-derived MSCs convert immunosuppressive tumor microenvironments (TMEs) into distinct Pro-inflammatory tmes

Engineered IL7/IL15 secreting iPSC-derived mesenchymal stromal cells reprogram the immunosuppressive tumor microenvironment and potentiate antitumor immunity

From mechanistic synergy to clinical breakthrough: Updated results from a phase II Trial of HD-MTX, selinexor, and zanubrutinib in CNS lymphoma

Quantitative 18F-FDG-PET/CT analysis of splenic suvmax enhances diagnostic accuracy in primary splenic non-Hodgkin lymphoma

Correlative data from an ongoing Phase 1, multicenter study of senti-202, a first-in-class, CD33 and/or FLT3 & not endomucin (EMCN), selective off-the-shelf CAR NK cell therapy for Acute Myeloid Leukemia (AML) is consistent with its clinical activity and unique logic gated mechanism of action

Reactivating mutant p53 in T cells enhances anti-tumor activity in Acute Myeloid Leukemia

Comparisons between Haploidentical Hematopoietic Stem Cell Transplantation and Eltrombopag Adding to Standard Immunosuppression in Patients with Severe Aplastic Anemia

Associations of Long-Term Financial Hardship with Autologous Transplant and Overall Survival in Patients with Multiple Myeloma

“Guided” Unsupervised Multiplexed Cytof Analysis Enhances Detection of Minimal/Measurable Residual Disease in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only